Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec;82(4):3741-3750.
doi: 10.1007/s12013-024-01461-z. Epub 2024 Sep 12.

In vitro Chondrogenic Induction Promotes the Expression Level of IL-10 via the TGF-β/SMAD and Canonical Wnt/β-catenin Signaling Pathways in Exosomes Secreted by Human Adipose Tissue-derived Mesenchymal Stem Cells

Tugba Semerci Sevimli  1 , Ulukan Inan  2 , Dilara Mantar  3 , Kubra Guler  4 , Zarifa Ahmadova  5 , Kadri Gulec  6 , Ahmet Emin Topal  4
Affiliations

In vitro Chondrogenic Induction Promotes the Expression Level of IL-10 via the TGF-β/SMAD and Canonical Wnt/β-catenin Signaling Pathways in Exosomes Secreted by Human Adipose Tissue-derived Mesenchymal Stem Cells

Tugba Semerci Sevimli et al. Cell Biochem Biophys. 2024 Dec.

Erratum in

Abstract

Current treatment approaches cannot exactly regenerate cartilage tissue. Regarding some problems encountered with cell therapy, exosomes are advantageous because of their "cell-free" nature. This study examines the relationship between IL-10 and TGF-β and Canonical Wnt/β-catenin signal pathways in human adipose tissue-derived MSCs exosomes (hAT-MSCs-Exos) after in vitro chondrogenic differentiation. Human adipose tissue-derived mesenchymal stem cells (hAT-MSCs) and, as a control group, human fetal chondroblast cells (hfCCs) were differentiated chondrogenically in vitro. Exosome isolation and characterization analyses were performed. Chondrogenic differentiation was shown by Alcian Blue and Safranin O stainings. The expression levels of IL-10, TGF-β/SMAD signaling pathway genes, and Canonical Wnt/β-catenin signaling pathway genes, which play an essential role in chondrogenesis, were analyzed by RT-qPCR. Conditioned media cytokine levels were measured by using the TGF-β and IL-10 ELISA kits. IL-10 expression was upregulated in both chondrogenic differentiated hAT-MSC-Exos (dhAT-MSC-Exos) (p < 0.0001). In the TGF-β signaling pathway, TGF-β (p < 0.0001), SMAD2 (p < 0.0001), SMAD4 (p < 0.001), ACAN (p < 0.0001), SOX9 (p < 0.05) and COL1A2 (p < 0.0001) expressions were upregulated in dhAT-MSC-Exos. SMAD3 expression was upregulated in non-differentiated hAT-MSC-Exos. In the Canonical Wnt/β-catenin signaling pathway, WNT (p < 0.0001) and CTNNB1(p < 0.0001) expressions were upregulated in dhAT-MSC-Exos. AXIN (p < 0.0001) expression was upregulated in non-differentiated hAT-MSC-Exos. TGF-β and IL-10 levels were higher in dhAT-MSCs) (p < 0.0001). Related to these results, IL-10 may induce TGF-β/SMAD and Canonical Wnt/β-catenin signaling pathways in hAT-MSC exosomes obtained after chondrogenic differentiation. Therefore, using these exosomes for cartilage regeneration can lead to the development of treatment methods.

Keywords: Canonical Wnt/β-catenin signaling; Chondrogenesis; IL-10; Mesenchymal stem cell-exosome; TGF-β signaling pathway.

PubMed Disclaimer

Conflict of interest statement

Compliance with Ethical Standards Conflict of interest The authors declare that they have no conflict of interest. Consent for Publication All the authors approved the publication.

References

    1. Liu, Y., Ma, Y., Zhang, J., Yuan, Y., & Wang, J. (2019). Exosomes: a novel therapeutic agent for cartilage and bone tissue regeneration. Dose-Response, 17(4), https://doi.org/10.1177/1559325819892702
    1. Toh, W.S. et al. (2016). MSC exosome as a cell-free MSC therapy for cartilage regeneration: Implications for osteoarthritis treatment. in Seminars in Cell & Developmental Biology. Elsevier. https://doi.org/10.1016/j.semcdb.2016.11.008
    1. Krishnan, Y., & Grodzinsky, A. J. (2018). Cartilage diseases. Matrix Biology, 71-72, 51–69. https://doi.org/10.1016/j.matbio.2018.05.005 . - DOI - PubMed - PMC
    1. Malekpour, K., Hazrati, A., Zahar, M., Markov, A., Zekiy, A. O., Navashenaq, J. G., Roshangar, L., & Ahmadi, M. (2022). The potential use of mesenchymal stem cells and their derived exosomes for orthopedic diseases treatment. Stem Cell Reviews and Reports, 18(3), 933–951. https://doi.org/10.1007/s12015-021-10185-z . - DOI - PubMed
    1. Goh, D., Yang, Y., Lee, E.H., Hui, J., & Yang, Z. (2023). Managing the heterogeneity of mesenchymal stem cells for cartilage regenerative therapy: a review. Bioengineering, 10(3), https://doi.org/10.3390/bioengineering10030355 .

MeSH terms

LinkOut - more resources